Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy

British Journal of Ophthalmology

Volumn 96, Issue 5, 2012, Pages 699-703

  Jackson, Gregory R ^a   Scott, Ingrid U ^a   Quillen, David A ^a   Walter, Laura E ^a   Gardner, Thomas W ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DARK ADAPTATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIGHT ADAPTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPROLIFERATIVE DIABETIC RETINOPATHY; PERIMETRY; PRIORITY JOURNAL; RETINA CONE; RETINA GANGLION CELL; RETINA ROD; RETINOPATHY; VISUAL ACUITY; VISUAL DISORDER;

ADULT; CONTRAST SENSITIVITY; DARK ADAPTATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINAL PHOTORECEPTOR CELL INNER SEGMENT; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS; YOUNG ADULT;

EID: 84860221553     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2011-300467     Document Type: Article

References (30)

1. Bresnick GH. Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol 1986;104:989-90.
2. Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011;52:1156-63.
3. Gardner TW, Abcouwer SF, Barber AJ, et al. An integrated approach to diabetic retinopathy research. Arch Ophthalmol 2011;129:230-5.
4. Abraham FA, Haimovitz J, Berezin M. The photopic and scotopic visual thresholds in diabetics without diabetic retinopathy. Metab Pediatr Syst Ophthalmol 1988;11:76-7.
5. Henson DB, Williams DE. Normative and clinical data with a new type of dark adaptometer. Am J Optom Physiol Opt 1979;56:267-71.
6. Verrotti A, Lobefalo L, Altobelli E, et al. Static perimetry and diabetic retinopathy: a long-term follow-up. Acta Diabetol 2001;38:99-105. (Pubitemid 33035319)
7. Giusti C. Lanthony 15-hue desaturated test for screening of early color vision defects in uncomplicated juvenile diabetes. Jpn J Ophthalmol 2001;45:607-11. (Pubitemid 34081774)
8. Daley ML, Watzke RC, Riddle MC. Early loss of blue-sensitive color vision in patients with type I diabetes. Diabetes Care 1987;10:777-81. (Pubitemid 18049836)
9. Han Y, Adams AJ, Bearse MA Jr, et al. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol 2004;122:1809-15. (Pubitemid 39602141)
10. Bengtsson B, Hellgren KJ, Agardh E. Test-retest variability for standard automated perimetry and short-wavelength automated perimetry in diabetic patients. Acta Ophthalmol 2008;86:170-6.
11. Remky A, Weber A, Hendricks S, et al. Short-wavelength automated perimetry in patients with diabetes mellitus without macular edema. Graefes Arch Clin Exp Ophthalmol 2003;241:468-71. (Pubitemid 36833743)
12. Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-91. (Pubitemid 28399611)
13. Gastinger MJ, Kunselman AR, Conboy EE, et al. Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci 2008;49:2635-42.
14. Abu-El-Asrar AM, Dralands L, Missotten L, et al. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci 2004;45:2760-6. (Pubitemid 38998875)
15. van Dijk HW, Kok PH, Garvin M, et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 2009;50:3404-9.
16. van Dijk HW, Verbraak FD, Kok PH, et al. Decreased retinal ganglion cell layer thickness in type 1 diabetic patients. Invest Ophthalmol Vis Sci 2010;51:3660-5.
17. Takahashi H, Chihara E. Impact of diabetic retinopathy on quantitative retinal nerve fiber layer measurement and glaucoma screening. Invest Ophthalmol Vis Sci 2008;49:687-92.
18. Greenstein VC, Hood DC, Ritch R, et al. S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci 1989;30:1732-7. (Pubitemid 19214993)
19. Jackson GR, Barber AJ. Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep 2010;10:380-4.
20. James AC, Maddess T, Rouhan K, et al. Evidence for My-cell involvement in the spatial frequency doubled illusion as revealed by multiple region PERG for glaucoma. J Opt Soc Am VSIA Techn Dig 1995;1:314-17.
21. Maddess T, Hemmi JM, James AC. Evidence for spatial aliasing effects in the y-like cells of the magnocellular visual pathway. Vision Res 1998;38:1843-59. (Pubitemid 28318774)
22. Jackson GR, Edwards JG. A short-duration dark adaptation protocol for the assessment of age-related maculopathy. J Ocul Biol Dis Infor 2008;1:7-11.
23. Parravano M, Oddone F, Mineo D, et al. The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes. Br J Ophthalmol 2008;92:1656-60.
24. Parikh R, Naik M, Mathai A, et al. Role of frequency doubling technology perimetry in screening of diabetic retinopathy. Indian J Ophthalmol 2006;54:17-22. (Pubitemid 43363571)
25. Greenstein VC, Thomas SR, Blaustein H, et al. Effects of early diabetic retinopathy on rod system sensitivity. Optom Vis Sci 1993;70:18-23. (Pubitemid 23173541)
26. Holopigian K, Seiple W, Lorenzo M, et al. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1992;33:2773-80.
27. Holopigian K, Greenstein VC, Seiple W, et al. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:2355-65. (Pubitemid 27446953)
28. Cabrera DeBuc D, Somfai GM. Early detection of retinal thickness changes in diabetes using optical coherence tomography. Med Sci Monit 2010;16:MT15-21.
29. Zeng H-y, Green WR, Tso MOM. Microglial activation in human diabetic retinopathy. Arch Ophthalmol 2008;126:227-32. (Pubitemid 351240852)
30. Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006;55:2401-11. (Pubitemid 44871140)